Found: 31
Select item for more details and to access through your institution.
Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S349, doi. 10.1093/cid/ciy623
- By:
- Publication type:
- Article
The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S336, doi. 10.1093/cid/ciy626
- By:
- Publication type:
- Article
Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S342, doi. 10.1093/cid/ciy612
- By:
- Publication type:
- Article
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S293, doi. 10.1093/cid/ciy611
- By:
- Publication type:
- Article
Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S274, doi. 10.1093/cid/ciy618
- By:
- Publication type:
- Article
Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S359, doi. 10.1093/cid/ciy627
- By:
- Publication type:
- Article
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S308, doi. 10.1093/cid/ciy624
- By:
- Publication type:
- Article
Artificial intelligence–derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S284, doi. 10.1093/cid/ciy610
- By:
- Publication type:
- Article
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S317, doi. 10.1093/cid/ciy609
- By:
- Publication type:
- Article
Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e230, doi. 10.1093/infdis/jiad545
- By:
- Publication type:
- Article
Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S102, doi. 10.1093/cid/ciw483
- By:
- Publication type:
- Article
Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S88, doi. 10.1093/cid/ciw473
- By:
- Publication type:
- Article
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S95, doi. 10.1093/cid/ciw474
- By:
- Publication type:
- Article
Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S80, doi. 10.1093/cid/ciw482
- By:
- Publication type:
- Article
A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S75, doi. 10.1093/cid/ciw472
- By:
- Publication type:
- Article
Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S63, doi. 10.1093/cid/ciw471
- By:
- Publication type:
- Article
Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.616294
- By:
- Publication type:
- Article
Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1024608
- By:
- Publication type:
- Article
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 4, p. 953, doi. 10.1093/jac/dkad029
- By:
- Publication type:
- Article
Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Once-a-week tigecycline for the treatment of drug-resistant TB.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Linezolid as treatment for pulmonary Mycobacterium avium disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article